Pioneering Therapies, Uniquely Delivered
ABOUT SCINAI
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.
INNOVATIVE IMMUNOTHERAPEUTIC TREATMENTS
Scinai is developing a pipeline of alpaca-derived innovative nanosized antibody therapies, addressing several diseases with large and growing patient demand.
BOUTIQUE CDMO
Leveraging our state-of-the-art GMP facility, Scinai’s CDMO business unit serves pharmaceutical, biotech, and alternative protein food tech companies with pilot and clinical process development and manufacturing.
VALUE
Well-positioned to bring innovative therapies to market with unique competencies and a multifaceted derisked strategy for success
